Lawrence Blonde et al <br/><br/>
Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial 

<br/><br/><label>Subjects--Topical Terms: </label><br/>Computer science, information & general works